ClinicalTrials.Veeva

Menu

Transcranial Random Noise Stimulation in Food Addiction Treatment (tRNS-FA)

H

Hôpital le Vinatier

Status

Terminated

Conditions

Overweight, Obesity and Other Hyperalimentation (E65-E68)

Treatments

Device: Active tRNS
Device: Sham tRNS

Study type

Interventional

Funder types

Other

Identifiers

NCT02717247
2015-A00028-41

Details and patient eligibility

About

Obesity is worldwide a public health problem. According to World Health Organization (WHO), overweight and obesity are the fifth death risk factor worldwide. At least 2.8 million adults die each year. Food addiction is one of the causes of obesity that may benefit from new therapeutic options.

Full description

Transcranial random noise stimulation is a noninvasive brain stimulation technic. The modulation of the electrical activity of the right and left dorsolateral prefrontal cortex (DLPFC) by tRNS is able to act on the phenomenon of craving in other addictions. This allows us to make the assumption that tRNS stimulation could constitute a treatment for food addiction especially in obesity.

Enrollment

13 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female or male between 18 and 65 years old
  • Patients suffering from obesity, with a BMI ≥ 30.
  • Food dependence score at the Yale Food addiction Scale ≥ 3

Exclusion criteria

  • Presence of a an other psychiatric diagnosis of Axis I (DSM IV);
  • Presence of addictive comorbidity other than food addiction
  • Psychotropic treatment;
  • Pregnancy or lactation;
  • Contraindication to fMRI .

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

13 participants in 2 patient groups

Active tRNS treatment
Experimental group
Description:
The intervention consists in active tRNS stimulation with cathode above the left dorsolateral prefrontal cortex (DLPFC) which corresponds to the F3 location given by the 10-20 system. Anode is above the right dorsalateral prefrontal cortex (F4). 100 (Hertz)Hz-650Hz, 2milliampere(mA), 30min, twice daily, 5 days
Treatment:
Device: Active tRNS
Placebo tRNS treatment
Sham Comparator group
Description:
The intervention consists in placebo or sham tRNS stimulation electrode are above F3 and F4. Voltage will be ramped at the begin and end of a stimulation for 30 seconds. Placebo stimulation will consist of just applying the ramps at the begin and end of the stimulation.
Treatment:
Device: Sham tRNS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems